All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Atherosclerosis and Cardiovascular Risk in Systemic Sclerosis

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10366814" target="_blank" >RIV/00216208:11110/17:10366814 - isvavai.cz</a>

  • Alternative codes found

    RIV/00023728:_____/17:N0000017

  • Result on the web

    <a href="https://www.intechopen.com/books/systemic-sclerosis/atherosclerosis-and-cardiovascular-risk-in-systemic-sclerosis" target="_blank" >https://www.intechopen.com/books/systemic-sclerosis/atherosclerosis-and-cardiovascular-risk-in-systemic-sclerosis</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.5772/67495" target="_blank" >10.5772/67495</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Atherosclerosis and Cardiovascular Risk in Systemic Sclerosis

  • Original language description

    Atherosclerosis (ATS) has been considered to be a degenerative disease affecting large and medium-sized arteries, resulting in a passive build-up of cholesterol in the artery wall. In the last decade, immune system was proved to play the key role in the pathogenesis of ATS, suggesting ATS to be more progressive and accelerated in chronic inflammatory conditions. Studies in patients with autoimmune diseases, particularly in the most prevalent ones such as rheumatoid arthritis and systemic lupus erythematosus, confirmed the significantly more serious atherosclerotic disease and increased cardiovascular (CV) risk compared to the general population, suggesting these diseases as an independent risk factor for CV diseases. There are only few studies evaluating ATS and CV risk in systemic sclerosis (SSc). Moreover, these studies present contradictory results. Furthermore, it is complicated to differentiate primary vascular affection related to the pathogenesis of SSc from the secondary vascular infliction due to ATS. Nevertheless, most of the studies to date suggest ATS and its clinical manifestations to be more prevalent in SSc. Future studies evaluating larger cohorts of patients are required to determine the relevance of ATS and CV disease and management of these comorbidities in SSc.

  • Czech name

  • Czech description

Classification

  • Type

    C - Chapter in a specialist book

  • CEP classification

  • OECD FORD branch

    30226 - Rheumatology

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Book/collection name

    Systemic sclerosis

  • ISBN

    978-953-51-3547-0

  • Number of pages of the result

    38

  • Pages from-to

    23-60

  • Number of pages of the book

    205

  • Publisher name

    Intech

  • Place of publication

    Rijeka

  • UT code for WoS chapter